Menlo Park, CA, United States of America

Christopher Scott Jones

This inventor holds 51 USPTO granted patents and 10 published patent applications, plus 3 CIPO patents and 9 EPO patents, primarily in Obesity Treatment. Top assignees: Vnus Medical Technologies, Inc., Fulfillium, Inc., Covidien LP. Active years: 2000-2026.

USPTO Granted Patents = 51 

% Patents Active = 56.9

 

 

Average Co-Inventor Count = 4.7

ph-index = 22

Forward Citations = 2,508(Granted Patents)


Location History:

  • Gales Ferry, CT (US) (2012 - 2013)
  • Sunnyvale, CA (US) (2000 - 2018)
  • Mountain View, CA (US) (2019)
  • Napa, CA (US) (2016 - 2021)
  • Menlo Park, CA (US) (2009 - 2023)

Company Filing History:


Years Active: 2000-2026

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Endoluminal Valve
Obesity Treatment
Tissue Expanders
Hernia Closure
Myringotomy
Vein Ligator
Coagulation Methods
Nipple Formation
Gastric Volume Control
Videoscopic Techniques
Cellulite Treatment
Tissue Transfer
51 patents (USPTO):Explore Patents

Title: The Inventor Christopher Scott Jones

Introduction: Christopher Scott Jones is a prolific inventor based in Menlo Park, California.

Latest Patents: Jones holds several patents in various fields, including technology, healthcare, and consumer products.

Career Highlights: With a career spanning over two decades, Jones has been recognized for his innovative solutions to complex problems. He has a track record of turning ideas into successful products that have made a positive impact on society.

Collaborations: Throughout his career, Jones has collaborated with leading companies, research institutions, and universities to bring his inventions to life. His ability to work across disciplines has led to groundbreaking innovations.

Conclusion: Christopher Scott Jones continues to push the boundaries of what is possible through his inventive spirit and dedication to creating a better future for all.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…